Drug Study

Hepatitis B vaccine is a vaccine developed for the prevention of hepatitis B virus infection. The vaccine

contains one of the viral envelope proteins, hepatitis B surface antigen (HBsAg). It is produced by yeast

cells, into which the genetic code for HBsAg has been inserted.

Minimum Ageat 1st Dose

Numberof Doses

Dose Minimum Interval Between Doses

Route Site Reason

At birth 3 doses 0.5ml 4 weeks Intramuscular Upper outer portion of the thigh, Vastus Lateralis (R-L-R)

An early start of Hepatitis B vaccine reduces the chance of being infected and becoming a carrier.Prevents liver cirrhosis and liver cancer which are more likely to develop if infected with Hepatitis B early in life. About 9,000 die of complications of Hepatitis B. 10% of Filipinos have Hepatitis B infection

Drug Study

Tetanus toxin is an extremely potent neurotoxin produced by the vegetative cell of Clostridium tetani[1] in anaerobic conditions, causing tetanus. It has no known function for clostridia in the soil environment where they are normally encountered. It is also called spasmogenic toxin, tetanospasmin or abbreviated to TeTx or TeNT.

When given to women of childbearing age, vaccines that contain tetanus toxoid (TT or Td) not only protect women against tetanus, but also prevent neonatal tetanus in their newborn infants.

VaccineMinimum

Age/IntervalPercent

ProtectedDuration of Protection

TT1As early as possibleduring pregnancy

80% protection for the mother for the first delivery

TT2At least 4 weeks later

80%

infants born to the mother will be protected from neonatal tetanus gives 3 years protection for the mother

TT3At least 6 monthslater

95%

infants born to the mother will be protected from neonatal tetanus gives 5 years protection for the mother

TT4At least 1 year later

99%

infants born to the mother will be protected from neonatal tetanus gives 10 years protection for the mother

TT5At least 1 year later

99%

gives lifetime protection for the mother all infants born to that mother will be protected